Athena Neurosciences Overview

  • Year Founded
  • 1986

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $625M

Athena Neurosciences General Information

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 800 Gateway Boulevard
  • San Francisco, CA 94080
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • 800 Gateway Boulevard
  • San Francisco, CA 94080
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Athena Neurosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 01-Jul-1996 $625M Completed Generating Revenue
6. IPO 07-Nov-1991 Completed Generating Revenue
5. Later Stage VC 11-Feb-1991 Completed Generating Revenue
4. Grant 01-Jan-1990 Completed Generating Revenue
3. Later Stage VC (Series C) 25-Apr-1988 Completed Generating Revenue
2. Early Stage VC (Series B) 01-Jan-1987 Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jan-1986 Completed Product Development
To view Athena Neurosciences’s complete valuation and funding history, request access »

Athena Neurosciences Patents

Athena Neurosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-5969950-A Enhanced heat sink attachment Inactive 04-Nov-1998
US-6241969-B1 Aerosolized mixture of corticosteroid and a high-hlb surfactant comprising a vitamin e ethoxylate Inactive 26-Jun-1998
CA-2335900-A1 Aqueous compositions containing corticosteroids for nasal and pulmonary delivery Active 26-Jun-1998
CA-2335900-C Aqueous compositions containing corticosteroids for nasal and pulmonary delivery Inactive 26-Jun-1998
EP-1089715-A1 Aqueous compositions containing corticosteroids for nasal and pulmonary delivery Active 26-Jun-1998 A61K9/0078
To view Athena Neurosciences’s complete patent history, request access »

Athena Neurosciences Former Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
ABR Capital Partners Real Estate Minority
Avalon Ventures Venture Capital Minority
BNP Paribas Investment Bank Minority
CW Group Venture Capital Minority
Domain Associates Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

Athena Neurosciences FAQs

  • When was Athena Neurosciences founded?

    Athena Neurosciences was founded in 1986.

  • Where is Athena Neurosciences headquartered?

    Athena Neurosciences is headquartered in San Francisco, CA.

  • What industry is Athena Neurosciences in?

    Athena Neurosciences’s primary industry is Drug Discovery.

  • Is Athena Neurosciences a private or public company?

    Athena Neurosciences is a Private company.

  • What is the current valuation of Athena Neurosciences?

    The current valuation of Athena Neurosciences is .

  • What is Athena Neurosciences’s current revenue?

    The current revenue for Athena Neurosciences is .

  • How much funding has Athena Neurosciences raised over time?

    Athena Neurosciences has raised $85M.

  • Who are Athena Neurosciences’s investors?

    ABR Capital Partners, Avalon Ventures, BNP Paribas, CW Group, and Domain Associates are 5 of 16 investors who have invested in Athena Neurosciences.

  • When was Athena Neurosciences acquired?

    Athena Neurosciences was acquired on 01-Jul-1996.

  • Who acquired Athena Neurosciences?

    Athena Neurosciences was acquired by Elan (Pharmaceuticals).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process